Page 1518 - Markets News

As RIL announces big capex plans, analysts fear dent in return ratios

Speaking at the AGM, Mukesh Ambani announced plans to invest Rs 2 trillion in set-up a nationwide fifth generation (5G) mobile network by the end of next year

Adani Enterprises to enter Nifty 50 index in a new boost for Gautam Adani

Adani Enterprises will replace Shree Cement in the most tracked stocks gauge in India on September 30

General Atlantic Singapore sells 1.66 mn shares of KIMS worth Rs 204 cr

General Atlantic Singapore Kh Pte Ltd on Thursday offloaded 16.60 lakh shares of hospital chain Krishna Institute of Medical Sciences Ltd (KIMS) for Rs 204 crore through an open market transaction

Sensex drops over 1,000 pts intra-day: Top factors behind Thursday's crash

Index heavyweights, Reliance Industries and Tata Consultancy Services contributed the most to the sharp cuts as they slipped between 2-3 per cent.

Sensex sinks 770 pts, Nifty gives up 17,550 amid global sell-off; PSBs soar

CLOSING BELL: Reliance Industries tanked 3 per cent today, contributing nearly 30 per cent of the losses on the Sensex

Zee Entertainment dips 6% amid reports of CCI scrutiny over Sony deal

According to a Reuters report, Competition Commission of India (CII), observed that the merger between the Indian unit of Sony and ZEE will potentially hurt competition

Dish TV, Nelco, NDTV, Reliance Capital and 242 others freeze upper circuit

As of 12.14 pm, these stocks gained between 5 per cent and 20 per cent, as against 0.85 per cent decline in the Sensex at 59,032 points.

Best Agrolife zooms 37% in 2 days after Ashish Kacholia buys 1% stake

On Tuesday, August 30, 2022, Ashish Rameshchandra Kacholia purchased 318,000 equity shares, representing 1.3 per cent stake in Best Agrolife for Rs 30 crore on the NSE, data shows.

Ashok Leyland rallies 5% on bagging order for 1,400 school buses in UAE

The stock surpassed its previous high of Rs 158.15 touched on August 1, 2022. It was trading close to its record high of Rs 168 touched on May 8, 2018

Biocon sheds 4%, hits 52-week low as US FDA issues form 483 for 3 sites

The US health regulator has issued Form 483s with 11 observations each for two sites in Bengaluru and six observations for a plant in Malaysia site.

Stocks to watch: Biocon, SpiceJet, PNB, NTPC, Ashok Leyland, Coffee Day

Stocks to watch today: Biocon received 11 observations in Form 483 for their Bengaluru and Mayalsia facilities from the USFDA; Ashok Leyland won orders from major fleets for 1,400 school buses in UAE.

Small-caps outperform large-caps but fail to match mid-caps in August

The Nifty Smallcap 100 Index rose 4.9 per cent. By comparison, the Nifty50 Index rose 3.5 per cent and the Nifty Midcap 100 soared 6.2 per cent

Fewer IPOs in 2022: How long before the primary market revs up?

As against over 60 companies that took the IPO route last year, only 16 companies have floated their initial public offers this year. Take a dive into the reasons behind the lull this year

Disappointing GDP data, weak global cues to weigh on market sentiments

Analysts said there are signs of the waning of the intensity of tailwind generated by economic reopening

BSE 200: Adani stocks outperform indices, Zomato down 57.8% in 2022 so far

Top gainers have surged between 50% and 315%, while new-age tech companies, such as Zomato and PB Fintech, have lost half their market value

Sebi bans 3 individuals from markets for unauthorised investment advisory

They have also been debarred from accessing as well as dealing in securities markets directly or indirectly in any manner for six months from the date of this completion of refunds to the investors.

Sebi imposes Rs 3 lakh fine on CB Management Services for non-compliance

CB Management Services, Registrar to an Issue and Share Transfer Agent, has been asked to pay the fine within 45 days, the Securities and Exchange Board of India (Sebi) said in an order on Tuesday.

Markets log 3rd highest monthly FPI inflows since Covid outbreak in August

Foreign investors pump in Rs 51,000 cr; near-term flows to hinge on rupee, bond movements

Primary market revival is still some time away, say analysts

Inflation trajectory and the actions of global central banks, especially the US Fed will be keenly watched by market participants. In this backdrop, primary markets will remain in wait and watch mode

Sanofi may underperform in near term; pricing control among key risks

The decline was largely on account of divestment of its nutraceutical business and a few key brands.